JVMCX
Price
$26.03
Change
+$0.25 (+0.97%)
Updated
Jun 6 closing price
Net Assets
21.45B
VVONX
Price
$22.05
Change
+$0.24 (+1.10%)
Updated
Jun 6 closing price
Net Assets
4.91B
Interact to see
Advertisement

JVMCX vs VVONX

Header iconJVMCX vs VVONX Comparison
Open Charts JVMCX vs VVONXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$26.03
Change+$0.25 (+0.97%)
VolumeN/A
Net Assets21.45B
Invesco Value Opportunities R5
Price$22.05
Change+$0.24 (+1.10%)
VolumeN/A
Net Assets4.91B
JVMCX vs VVONX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMCX vs. VVONX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and VVONX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. VVONX (4.92B). VVONX pays higher dividends than JVMCX: VVONX (0.63) vs JVMCX (0.00). JVMCX was incepted earlier than VVONX: JVMCX (14 years) vs VVONX (14 years). JVMCX (1.88) is less costly to investors than VVONX (0.76). JVMCX (47.00) and VVONX (47.00) have comparable annual turnover. JVMCX has a lower initial minimum investment than VVONX: JVMCX (1000) vs VVONX (1000000). VVONX annual gain was more profitable for investors over the last year : 7.65 vs. JVMCX (-4.66). VVONX return over 5 years is better than : 94.52 vs. JVMCX (33.39).
JVMCXVVONXJVMCX / VVONX
Total Expense Ratio1.870.76246%
Annual Report Gross Expense Ratio1.880.76247%
Fund Existence14 years14 years-
Gain YTD1.897-0.183-1,036%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.5B4.92B437%
Annual Yield % from dividends0.000.63-
Returns for 1 year-4.667.65-61%
Returns for 3 years1.4723.576%
Returns for 5 years33.3994.5235%
Returns for 10 years25.9650.9351%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FTXL87.420.37
+0.43%
First Trust Nasdaq Semiconductor ETF
VUSB49.61-0.01
-0.02%
Vanguard Ultra-Short Bond ETF
XPP24.45-0.05
-0.22%
ProShares Ultra FTSE China 50
PCRB48.16-0.25
-0.52%
Putnam ESG Core Bond ETF